|
[1]NAJJAR SM.Regulation of insulin action by CEACAM1[J].Trends Endocrinol Metab, 2002, 13 (6) :240-245.
|
|
[2]MATVEYENKO AV, LIUWANTARA D, GURLO T, et al.Pulsatile portal vein insulin delivery enhances hepatic insulinaction and signaling[J].Diabetes, 2012, 61 (9) :2269-2279.
|
|
[3]GHOSH S, KAW M, PATEL PR, et al.Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis[J].Hepat Med, 2010, 2010 (2) :69-78.
|
|
[4]COOK JR, LANGLET F, KIDO Y, et al.Pathogenesis of selective insulin resistance in isolated hepatocytes[J].J Biol Chem, 2015, 290 (22) :13972-13980.
|
|
[5]NAGAISHI T, PAO L, LIN SH, et al.SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms[J].Immunity, 2006, 25 (5) :769-781.
|
|
[6]HEINRICH G, GHADIEH HE, GHANEM SS, et al.Loss of hepatic CEACAM1:a unifying mechanism linking insulin resistance to obesity and non-alcoholic fatty liver disease[J].Front Endocrinol (Lausanne) , 2017, 8:8.
|
|
[7]ELIADES M, SPYROU E, AGRAWAL N, et al.Meta-analysis:vitamin D and non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther, 2013, 38 (3) :246-254.
|
|
[8]SU D, NIE Y, ZHU A, et al.Vitamin D signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models[J].Front Physiol, 2016, 7:498.
|
|
[9]ROTH CL, ELFERS CT, FIGLEWICZ DP, et al.Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation[J].Hepatology, 2012, 55 (4) :1103-1111.
|
|
[10]KONG M, ZHU L, BAI L, et al.Vitamin D deficiency promotes nonalcoholic steatohepatitis through impaired enterohepatic circulation in animal model[J].Am J Physiol Gastrointest Liver Physiol, 2014, 307 (9) :g883-g893.
|
|
[11]ZHU L, KONG M, HAN YP, et al.Spontaneous liver fibrosis induced by long term dietary vitamin D deficiency in adult mice is related to chronic inflammation and enhanced apoptosis[J].Can J Physiol Pharmacol, 2015, 93 (5) :385-394.
|
|
[12]HAMZAOUI A, BERRAES A, HAMDI B, et al.Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children[J].Immunobiology, 2014, 219 (11) :873-879.
|
|
[13]KESSLER RC, MERIKANGAS KR, WANG PS.Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century[J].Annu Rev Clin Psychol, 2007, 3:137-158.
|
|
[14]WEINSTEIR AA, KALLMAN PRICE J, STEPANOVA M, et al.Depression in patients with nonalcoholic fatty liver disease and chronic viral hepatitis B and C[J].Psychosomatics, 2011, 52 (2) :127-132.
|
|
[15]MACAVEI B, BABAN A, DUMITRASCU DL.Psychological factors associated with NAFLD/NASH:a systematic review[J].Eur Rev Med Pharmacol Sci, 2016, 20 (24) :5081-5097.
|
|
[16]YOUSSEF NA, ABDELMALEK MF, BINKS M, et al.Associations of depression, anxiety and antidepressants with histological severity of nonalcoholic fatty liver disease[J].Liver Int, 2013, 33 (7) :1062-1070.
|
|
[17]ELWING JE, LUSTMAN PJ, WANG HL, et al.Depression, anxiety, and nonalcoholic steatohepatitis[J].Psychosom Med, 2006, 68 (4) :563-569.
|
|
[18]DAVIES L, KARTHIKEYAN N, LYNCH JT, et al.Cross talk of signaling pathways in the regulation of the glucocorticoid receptor function[J].Mol Endocrinol, 2008, 22 (6) :1331-1344.
|
|
[19]MAGDY YM, EL-KHARASHI OA, NABIH ES, et al.Potential involvement of JNK1 repression in the hepatic effect of sitagliptin and metformin in rats subjected to high fat diet and chronic mild distress[J].Biomed Pharmacother, 2017, 85:225-238.
|
|
[20]MARDERSTEIN EL, BUCHER B, GUO Z, et al.Protection of rat hepatocytes from apoptosis by inhibition of c-Jun N-terminal kinase[J].Surgery, 2003, 134 (2) :280-284.
|
DownLoad: